Axsome Thera (AXSM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,211 | -6,001 | -2,167 | N/A | N/A |
| Depreciation Amortization | 54 | -2,505 | 192 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,134 | 599 | 158 | N/A | N/A |
| Other Working Capital | 938 | 515 | 153 | N/A | N/A |
| Other Operating Activity | 2,646 | 2,796 | 33 | 0 | 0 |
| Operating Cash Flow | $-7,439 | $-4,596 | $-1,631 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -20 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-20 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 7,383 | 5,210 | 3,775 | N/A | N/A |
| Debt Repayment | -42 | -21 | N/A | N/A | N/A |
| Common Stock Issued | 45,549 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -13 | -63 | -58 | 0 | 0 |
| Financing Cash Flow | $52,878 | $5,126 | $3,717 | $N/A | $N/A |
| Beginning Cash Position | 2,618 | 2,088 | 2 | N/A | N/A |
| End Cash Position | 48,036 | 2,618 | 2,088 | N/A | N/A |
| Net Cash Flow | $45,419 | $530 | $2,086 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,439 | -4,596 | -1,631 | N/A | N/A |
| Capital Expenditure | -20 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -7,459 | -4,596 | -1,631 | 0 | 0 |